Available in French only
Les bénéfices de la pharmacogénétique en entreprise
February 6th, 2019
Michel Cameron, PhD
Associate Director ,Pharmacogenomics Medical Science LiaisonLinkedIn
Seeking to make the science of genetics accessible for everyone, in 2014 Michel Cameron co-founded BiogeniQ, a company specialized in genetics, where he directed the design and development of pharmacogenomics tests. Today this company is owned by Biron. Michel Cameron holds a Ph.D. in pharmacology from the Université de Montréal and completed postdoctoral studies in pharmacogenomics at the Montreal Heart Institute’s Pharmacogenomics Centre.